Your browser doesn't support javascript.
loading
Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium.
Kast, Karin; John, Esther M; Hopper, John L; Andrieu, Nadine; Noguès, Catherine; Mouret-Fourme, Emmanuelle; Lasset, Christine; Fricker, Jean-Pierre; Berthet, Pascaline; Mari, Véronique; Salle, Lucie; Schmidt, Marjanka K; Ausems, Margreet G E M; Garcia, Encarnacion B Gomez; van de Beek, Irma; Wevers, Marijke R; Evans, D Gareth; Tischkowitz, Marc; Lalloo, Fiona; Cook, Jackie; Izatt, Louise; Tripathi, Vishakha; Snape, Katie; Musgrave, Hannah; Sharif, Saba; Murray, Jennie; Colonna, Sarah V; Andrulis, Irene L; Daly, Mary B; Southey, Melissa C; de la Hoya, Miguel; Osorio, Ana; Foretova, Lenka; Berkova, Dita; Gerdes, Anne-Marie; Olah, Edith; Jakubowska, Anna; Singer, Christian F; Tan, Yen; Augustinsson, Annelie; Rantala, Johanna; Simard, Jacques; Schmutzler, Rita K; Milne, Roger L; Phillips, Kelly-Anne; Terry, Mary Beth; Goldgar, David; van Leeuwen, Flora E; Mooij, Thea M; Antoniou, Antonis C.
Afiliación
  • Kast K; Center for Hereditary Breast and Ovarian Cancer, Center for Integrated Oncology (CIO), Medical Faculty, University Hospital Cologne, Kerpener Str. 62, 50937, Cologne, Germany. karin.kast@uk-koeln.de.
  • John EM; Department of Epidemiology & Population Health and of Medicine (Oncology), Stanford University School of Medicine, Stanford, CA, USA.
  • Hopper JL; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
  • Andrieu N; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia.
  • Noguès C; INSERM U900, Paris, France.
  • Mouret-Fourme E; Institut Curie, Paris, France.
  • Lasset C; Mines Paris Tech, Fontainebleau, France.
  • Fricker JP; PSL Research University, Paris, France.
  • Berthet P; Aix Marseille Université, INSERM, IRD, SESSTIM, Marseille, France.
  • Mari V; Département d'Anticipation et de Suivi Des Cancers, Oncogénétique Clinique, Institut Paoli-Calmettes, Marseille, France.
  • Salle L; Institut Curie, Paris, France.
  • Schmidt MK; Centre Léon Bérard, Lyon, France.
  • Ausems MGEM; CRLCC Paul Strauss, Strasbourg, France.
  • Garcia EBG; Centre François Baclesse, Caen, France.
  • van de Beek I; Centre Antoine Lacassagne, Nice, France.
  • Wevers MR; Oncogénétique Poitou-Charentes, Niort, France.
  • Evans DG; Division of Molecular Pathology, Netherlands Cancer Institute, Antoni Van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Tischkowitz M; Department of Genetics, Division Laboratories, Pharmacy and Biomedical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Lalloo F; Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Cook J; Department of Human Genetics, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Izatt L; Department of Clinical Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Tripathi V; The Prevent Breast Cancer Research Unit, The Nightingale Centre, Manchester University NHS Foundation Trust, Manchester, UK.
  • Snape K; Genomic Medicine, Division of Evolution and Genomic Sciences, The University of Manchester, St Mary's Hospital, Manchester University NHS Foundation Trust, Manchester, UK.
  • Musgrave H; Manchester Breast Centre, Oglesby Cancer Research Centre, The Christie, University of Manchester, Manchester, UK.
  • Sharif S; Department of Medical Genetics, National Institute for Health Research Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, UK.
  • Murray J; Clinical Genetics Service, Manchester Centre for Genomic Medicine, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
  • Colonna SV; Department of Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Andrulis IL; Clinical Genetics Service, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Daly MB; Department of Clinical Genetics, St George's University Hospitals NHS Foundation Trust, London, UK.
  • Southey MC; Yorkshire Regional Genetics Service, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
  • de la Hoya M; West Midlands Regional Genetics Service, Birmingham Women's Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK.
  • Osorio A; Yorkshire Regional Genetics Service, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
  • Foretova L; West Midlands Regional Genetics Service, Birmingham Women's Hospital Healthcare NHS Trust, Edgbaston, Birmingham, UK.
  • Berkova D; South East of Scotland Regional Genetics Service, Western General Hospital, Edinburgh, UK.
  • Gerdes AM; MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.
  • Jakubowska A; Department of Medicine and Huntsman Cancer Institute, University of Utah Health, Salt Lake City, UT, USA.
  • Singer CF; Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, ON, Canada.
  • Tan Y; Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
  • Augustinsson A; Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA, USA.
  • Rantala J; Precision Medicine, School of Clinical Sciences at, Monash Health Monash University, Clayton, VIC, Australia.
  • Simard J; Department of Clinical Pathology, The University of Melbourne, Melbourne, VIC, Australia.
  • Schmutzler RK; Molecular Oncology Laboratory, Hospital Clínico San Carlos, IdISSC (Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Madrid, Spain.
  • Milne RL; Familial Cancer Clinical Unit, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO) and Spanish Network On Rare Diseases (CIBERER), Madrid, Spain.
  • Phillips KA; Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
  • Terry MB; Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
  • Goldgar D; Department of Clinical Genetics, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • van Leeuwen FE; Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary.
  • Mooij TM; Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
  • Antoniou AC; Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, Szczecin, Poland.
Breast Cancer Res ; 25(1): 72, 2023 06 20.
Article en En | MEDLINE | ID: mdl-37340476
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Genes BRCA2 Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Genes BRCA2 Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans Idioma: En Año: 2023 Tipo del documento: Article